Disse B

General

Full name : Disse Bernd

First name : Bernd

Mail : Boehringer Ingelheim Pharma GmBH & Co, Ingelheim

Zip Code :

City :

Country : Germany

Email :

Phone :

Fax :

Website :

Directory :

References (9)

Title : The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale - Wise_2013_Respir.Res_14_40
Author(s) : Wise RA , Anzueto A , Calverley P , Dahl R , Dusser D , Pledger G , Koenen-Bergmann M , Joseph E , Cotton D , Disse B
Ref : Respir Res , 14 :40 , 2013
Abstract :
PubMedSearch : Wise_2013_Respir.Res_14_40
PubMedID: 23547660

Title : Tiotropium Respimat inhaler and the risk of death in COPD - Wise_2013_N.Engl.J.Med_369_1491
Author(s) : Wise RA , Anzueto A , Cotton D , Dahl R , Devins T , Disse B , Dusser D , Joseph E , Kattenbeck S , Koenen-Bergmann M , Pledger G , Calverley P
Ref : N Engl J Med , 369 :1491 , 2013
Abstract :
PubMedSearch : Wise_2013_N.Engl.J.Med_369_1491
PubMedID: 23992515

Title : Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial - Kerstjens_2011_J.Allergy.Clin.Immunol_128_308
Author(s) : Kerstjens HA , Disse B , Schroder-Babo W , Bantje TA , Gahlemann M , Sigmund R , Engel M , van Noord JA
Ref : J Allergy Clin Immunol , 128 :308 , 2011
Abstract :
PubMedSearch : Kerstjens_2011_J.Allergy.Clin.Immunol_128_308
PubMedID: 21636120

Title : Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies - Bateman_2010_Int.J.Chron.Obstruct.Pulmon.Dis_5_197
Author(s) : Bateman E , Singh D , Smith D , Disse B , Towse L , Massey D , Blatchford J , Pavia D , Hodder R
Ref : Int J Chron Obstruct Pulmon Dis , 5 :197 , 2010
Abstract :
PubMedSearch : Bateman_2010_Int.J.Chron.Obstruct.Pulmon.Dis_5_197
PubMedID: 20714373

Title : Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD - van Noord_2005_Eur.Respir.J_26_214
Author(s) : van Noord JA , Aumann JL , Janssens E , Smeets JJ , Verhaert J , Disse B , Mueller A , Cornelissen PJ
Ref : Eur Respir J , 26 :214 , 2005
Abstract :
PubMedSearch : van Noord_2005_Eur.Respir.J_26_214
PubMedID: 16055868

Title : Antimuscarinic treatment for lung diseases from research to clinical practice - Disse_2001_Life.Sci_68(22-23)_2557
Author(s) : Disse B
Ref : Life Sciences , 68 :2557 , 2001
Abstract :
PubMedSearch : Disse_2001_Life.Sci_68(22-23)_2557
PubMedID: 11392626

Title : Inhaled anticholinergic therapy: applied pharmacology and interesting developments -
Author(s) : Witek TJ, Jr. , Disse B
Ref : Curr Opin Investig Drugs , 2 :53 , 2001
PubMedID: 11527013

Title : Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease - Disse_1999_Life.Sci_64(6-7)_457
Author(s) : Disse B , Speck GA , Rominger KL , Witek TJ, Jr. , Hammer R
Ref : Life Sciences , 64 :457 , 1999
Abstract :
PubMedSearch : Disse_1999_Life.Sci_64(6-7)_457
PubMedID: 10069510

Title : Ba 679 BR, a novel long-acting anticholinergic bronchodilator - Disse_1993_Life.Sci_52(5-6)_537
Author(s) : Disse B , Reichl R , Speck G , Traunecker W , Ludwig Rominger KL , Hammer R
Ref : Life Sciences , 52 :537 , 1993
Abstract :
PubMedSearch : Disse_1993_Life.Sci_52(5-6)_537
PubMedID: 8441333